Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified family nurse practitioner (FNP) is reviewing the legal
responsibilities associated with prescribing medications in a primary
care clinic. Which action best demonstrates appropriate professional
accountability as an APRN prescriber?
A. Prescribing medications based primarily on recommendations from
pharmaceutical representatives
B. Prescribing only within the scope of education, certification, state
regulations, and clinical competence
C. Delegating all medication selection decisions to collaborating
physicians
D. Avoiding controlled substance prescribing regardless of patient need
Correct Answer: B
Rationale: APRNs are professionally and legally accountable for
prescribing within their education, certification, licensure, state scope
of practice, and clinical competence. Evidence-based prescribing and
patient safety are central responsibilities. Option A introduces potential
bias and is inappropriate. Option C does not reflect APRN autonomy
where permitted and does not eliminate prescriber responsibility.
Option D may result in undertreatment of appropriate clinical
conditions.
,Question 2
An APRN evaluates a 62-year-old man with hypertension, diabetes, and
chronic kidney disease. Before initiating a new antihypertensive
medication, which action best reflects evidence-based prescribing?
A. Select the medication with the lowest acquisition cost
B. Consider the patient's comorbidities, kidney function, concurrent
medications, and treatment goals
C. Delay treatment until every diagnostic test is completed
D. Prescribe the medication most commonly used by colleagues
Correct Answer: B
Rationale: Safe prescribing requires individualized assessment that
incorporates comorbidities, renal function, medication interactions,
patient preferences, and therapeutic goals. Cost is one consideration
but should not outweigh clinical appropriateness. Waiting unnecessarily
delays treatment, and prescribing based solely on colleague preference
lacks individualized clinical reasoning.
Question 3
A patient asks an APRN why a generic medication is being prescribed
instead of the brand-name product. Which response is most
appropriate?
A. "Generic medications are always less effective than brand-name
drugs."
B. "Generic medications contain different active ingredients."
, C. "FDA-approved generic medications are expected to provide
comparable safety, quality, and therapeutic effectiveness for approved
indications."
D. "Insurance companies require generic medications regardless of
clinical effectiveness."
Correct Answer: C
Rationale: FDA-approved generics must demonstrate bioequivalence
and comparable quality, safety, and effectiveness for approved uses.
Generic products do not contain different active ingredients and are
not inherently less effective. Insurance formularies may encourage
generic use, but clinical equivalence is the primary rationale.
Question 4
A patient with newly diagnosed asthma expresses concern about
starting long-term medication therapy. Which communication strategy
best supports shared decision-making?
A. Tell the patient that treatment decisions belong exclusively to the
clinician.
B. Present treatment options, discuss risks and benefits, and
incorporate the patient's preferences into the management plan.
C. Recommend delaying treatment until symptoms worsen.
D. Provide the prescription without discussing expected outcomes.
Correct Answer: B
Rationale: Shared decision-making improves adherence and patient
satisfaction by integrating evidence with patient values and
preferences. Patients should receive sufficient information to make
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified family nurse practitioner (FNP) is reviewing the legal
responsibilities associated with prescribing medications in a primary
care clinic. Which action best demonstrates appropriate professional
accountability as an APRN prescriber?
A. Prescribing medications based primarily on recommendations from
pharmaceutical representatives
B. Prescribing only within the scope of education, certification, state
regulations, and clinical competence
C. Delegating all medication selection decisions to collaborating
physicians
D. Avoiding controlled substance prescribing regardless of patient need
Correct Answer: B
Rationale: APRNs are professionally and legally accountable for
prescribing within their education, certification, licensure, state scope
of practice, and clinical competence. Evidence-based prescribing and
patient safety are central responsibilities. Option A introduces potential
bias and is inappropriate. Option C does not reflect APRN autonomy
where permitted and does not eliminate prescriber responsibility.
Option D may result in undertreatment of appropriate clinical
conditions.
,Question 2
An APRN evaluates a 62-year-old man with hypertension, diabetes, and
chronic kidney disease. Before initiating a new antihypertensive
medication, which action best reflects evidence-based prescribing?
A. Select the medication with the lowest acquisition cost
B. Consider the patient's comorbidities, kidney function, concurrent
medications, and treatment goals
C. Delay treatment until every diagnostic test is completed
D. Prescribe the medication most commonly used by colleagues
Correct Answer: B
Rationale: Safe prescribing requires individualized assessment that
incorporates comorbidities, renal function, medication interactions,
patient preferences, and therapeutic goals. Cost is one consideration
but should not outweigh clinical appropriateness. Waiting unnecessarily
delays treatment, and prescribing based solely on colleague preference
lacks individualized clinical reasoning.
Question 3
A patient asks an APRN why a generic medication is being prescribed
instead of the brand-name product. Which response is most
appropriate?
A. "Generic medications are always less effective than brand-name
drugs."
B. "Generic medications contain different active ingredients."
, C. "FDA-approved generic medications are expected to provide
comparable safety, quality, and therapeutic effectiveness for approved
indications."
D. "Insurance companies require generic medications regardless of
clinical effectiveness."
Correct Answer: C
Rationale: FDA-approved generics must demonstrate bioequivalence
and comparable quality, safety, and effectiveness for approved uses.
Generic products do not contain different active ingredients and are
not inherently less effective. Insurance formularies may encourage
generic use, but clinical equivalence is the primary rationale.
Question 4
A patient with newly diagnosed asthma expresses concern about
starting long-term medication therapy. Which communication strategy
best supports shared decision-making?
A. Tell the patient that treatment decisions belong exclusively to the
clinician.
B. Present treatment options, discuss risks and benefits, and
incorporate the patient's preferences into the management plan.
C. Recommend delaying treatment until symptoms worsen.
D. Provide the prescription without discussing expected outcomes.
Correct Answer: B
Rationale: Shared decision-making improves adherence and patient
satisfaction by integrating evidence with patient values and
preferences. Patients should receive sufficient information to make
